Cargando…
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
BACKGROUND: Pisa syndrome (PS) is a frequent postural complication of Parkinson's disease (PD). PS poorly responds to anti-parkinsonian drugs and the improvement achieved with neurorehabilitation tends to fade in 6 months or less. Transcranial direct current stimulation (t-DCS) is a non-invasiv...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046718/ https://www.ncbi.nlm.nih.gov/pubmed/35493824 http://dx.doi.org/10.3389/fneur.2022.849820 |
_version_ | 1784695571231014912 |
---|---|
author | De Icco, Roberto Putortì, Alessia Allena, Marta Avenali, Micol Dagna, Carlotta Martinelli, Daniele Cristina, Silvano Grillo, Valentina Fresia, Mauro Bitetto, Vito Cosentino, Giuseppe Valentino, Francesca Alfonsi, Enrico Sandrini, Giorgio Pisani, Antonio Tassorelli, Cristina |
author_facet | De Icco, Roberto Putortì, Alessia Allena, Marta Avenali, Micol Dagna, Carlotta Martinelli, Daniele Cristina, Silvano Grillo, Valentina Fresia, Mauro Bitetto, Vito Cosentino, Giuseppe Valentino, Francesca Alfonsi, Enrico Sandrini, Giorgio Pisani, Antonio Tassorelli, Cristina |
author_sort | De Icco, Roberto |
collection | PubMed |
description | BACKGROUND: Pisa syndrome (PS) is a frequent postural complication of Parkinson's disease (PD). PS poorly responds to anti-parkinsonian drugs and the improvement achieved with neurorehabilitation tends to fade in 6 months or less. Transcranial direct current stimulation (t-DCS) is a non-invasive neuromodulation technique that showed promising results in improving specific symptoms in different movement disorders. OBJECTIVES: This study aimed to evaluate the role of bi-hemispheric t-DCS as an add-on to a standardized hospital rehabilitation program in the management of PS in PD. METHODS: This study included 28 patients with PD and PS (21 men, aged 72.9 ± 5.1 years) who underwent a 4-week intensive neurorehabilitation treatment and were randomized to receive: i) t-DCS (t-DCS group, n = 13) for 5 daily sessions (20 min−2 mA) with bi-hemispheric stimulation over the primary motor cortex (M1), or ii) sham stimulation (sham group, n = 15) with the same duration and cadence. At baseline (T0), end of rehabilitation (T1), and 6 months later (T2) patients were evaluated with both trunk kinematic analysis and clinical scales, including UPDRS-III, Functional Independence Measure (FIM), and Numerical Rating Scale for lumbar pain. RESULTS: When compared to the sham group, the t-DCS group achieved a more pronounced improvement in several variables: overall posture (p = 0.014), lateral trunk inclination (p = 0.013) during upright standing position, total range of motion of the trunk (p = 0.012), FIM score (p = 0.048), and lumbar pain intensity (p = 0.017). CONCLUSIONS: Our data support the use of neuromodulation with t-DCS as an add-on to neurorehabilitation for the treatment of patients affected by PS in PD. |
format | Online Article Text |
id | pubmed-9046718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90467182022-04-29 Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial De Icco, Roberto Putortì, Alessia Allena, Marta Avenali, Micol Dagna, Carlotta Martinelli, Daniele Cristina, Silvano Grillo, Valentina Fresia, Mauro Bitetto, Vito Cosentino, Giuseppe Valentino, Francesca Alfonsi, Enrico Sandrini, Giorgio Pisani, Antonio Tassorelli, Cristina Front Neurol Neurology BACKGROUND: Pisa syndrome (PS) is a frequent postural complication of Parkinson's disease (PD). PS poorly responds to anti-parkinsonian drugs and the improvement achieved with neurorehabilitation tends to fade in 6 months or less. Transcranial direct current stimulation (t-DCS) is a non-invasive neuromodulation technique that showed promising results in improving specific symptoms in different movement disorders. OBJECTIVES: This study aimed to evaluate the role of bi-hemispheric t-DCS as an add-on to a standardized hospital rehabilitation program in the management of PS in PD. METHODS: This study included 28 patients with PD and PS (21 men, aged 72.9 ± 5.1 years) who underwent a 4-week intensive neurorehabilitation treatment and were randomized to receive: i) t-DCS (t-DCS group, n = 13) for 5 daily sessions (20 min−2 mA) with bi-hemispheric stimulation over the primary motor cortex (M1), or ii) sham stimulation (sham group, n = 15) with the same duration and cadence. At baseline (T0), end of rehabilitation (T1), and 6 months later (T2) patients were evaluated with both trunk kinematic analysis and clinical scales, including UPDRS-III, Functional Independence Measure (FIM), and Numerical Rating Scale for lumbar pain. RESULTS: When compared to the sham group, the t-DCS group achieved a more pronounced improvement in several variables: overall posture (p = 0.014), lateral trunk inclination (p = 0.013) during upright standing position, total range of motion of the trunk (p = 0.012), FIM score (p = 0.048), and lumbar pain intensity (p = 0.017). CONCLUSIONS: Our data support the use of neuromodulation with t-DCS as an add-on to neurorehabilitation for the treatment of patients affected by PS in PD. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9046718/ /pubmed/35493824 http://dx.doi.org/10.3389/fneur.2022.849820 Text en Copyright © 2022 De Icco, Putortì, Allena, Avenali, Dagna, Martinelli, Cristina, Grillo, Fresia, Bitetto, Cosentino, Valentino, Alfonsi, Sandrini, Pisani and Tassorelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology De Icco, Roberto Putortì, Alessia Allena, Marta Avenali, Micol Dagna, Carlotta Martinelli, Daniele Cristina, Silvano Grillo, Valentina Fresia, Mauro Bitetto, Vito Cosentino, Giuseppe Valentino, Francesca Alfonsi, Enrico Sandrini, Giorgio Pisani, Antonio Tassorelli, Cristina Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial |
title | Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial |
title_full | Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial |
title_fullStr | Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial |
title_full_unstemmed | Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial |
title_short | Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial |
title_sort | non-invasive neuromodulation in the rehabilitation of pisa syndrome in parkinson's disease: a randomized controlled trial |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046718/ https://www.ncbi.nlm.nih.gov/pubmed/35493824 http://dx.doi.org/10.3389/fneur.2022.849820 |
work_keys_str_mv | AT deiccoroberto noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT putortialessia noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT allenamarta noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT avenalimicol noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT dagnacarlotta noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT martinellidaniele noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT cristinasilvano noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT grillovalentina noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT fresiamauro noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT bitettovito noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT cosentinogiuseppe noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT valentinofrancesca noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT alfonsienrico noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT sandrinigiorgio noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT pisaniantonio noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial AT tassorellicristina noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial |